BMI View: Rising healthcare expenditure will be one of the key drivers of pharmaceutical growth in the Philippines as the country’s intention to provide universal healthcare coverage sets the stage for increased access to health and pharmaceutical services. In addition to improving access to healthcare, the country is also looking to boost efforts in research and medical tourism. If successful, this will boost Philippines’s pharmaceutical business environment. A downside risk to our view is that the majority of the South East Asian countries are also looking to boost their efforts in these three functions, and the country will therefore have …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=111972.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/philippines-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment